These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The development of chronic renal allograft rejection may be predicted early following transplantation. O'Malley KJ; Cook DJ; Flechner SM; McCarthy JF; Thorne NA; Boparai N; Mastroianni BA; Papajcik DA; Modlin CS; Goldfarb DA; Novick AG Transplant Proc; 1999; 31(1-2):1352-3. PubMed ID: 10083599 [No Abstract] [Full Text] [Related]
28. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216 [No Abstract] [Full Text] [Related]
29. Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation. al-Hussein KA; Shenton BK; Bell A; Talbot D; White MD; Clark KR; Rigg KM; Forsythe J; Proud G; Taylor RM Transplant Proc; 1993 Feb; 25(1 Pt 1):259-61. PubMed ID: 8438293 [No Abstract] [Full Text] [Related]
30. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related]
31. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody. Shoker A; Klassen J; Herbut B Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants. Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065 [TBL] [Abstract][Full Text] [Related]